🔎 Trials Near Me

Akèy › Twoub depresif majè › Florid › Tampa

Etid klinik pou Twoub depresif majè nan Tampa, FL

17 etid pou Twoub depresif majè ap chèche patisipan nan sit nan ak bò kote Tampa (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder

Ap rekriteFaz 3
  • IPTB Clinical Research, Tampa
Laj 18 a 74 · Tout sèks · Mizajou Oct 1, 2026 · NCT07573176

Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms

Ap rekriteFaz 3
  • Psych Me Medical Research Inc, Tampa
  • Interventional Psychiatry of Tampa Bay, Tampa
Laj 18 a 74 · Tout sèks · Mizajou Sep 25, 2026 · NCT06559306

A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)

Ap rekriteFaz 2
  • K2 Medical Research - Tampa, Tampa
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07621237

Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder

Ap rekriteFaz 3
  • Interventional Psychiatry of Tampa Bay, Tampa
Laj 18 a 65 · Tout sèks · Mizajou Sep 25, 2026 · NCT05850689

A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

Ap rekriteFaz 3
  • K2 Medical Research Tampa, Tampa
Laj 18 a 85 · Tout sèks · Mizajou Sep 25, 2026 · NCT06793397

ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response

Ap rekriteFaz 2
  • IPTB Clinical Research, Tampa
Laj 18 a 65 · Tout sèks · Mizajou Sep 14, 2026 · NCT07284667

A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression

Ap rekriteFaz 2
  • Draig Clinical Site, Tampa
  • Draig Clinical Site, Tampa
Laj 18 a 75 · Tout sèks · Mizajou Sep 2, 2026 · NCT07610473

Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)

Ap rekrite
  • USF Health, Tampa
Laj 22 a 70 · Tout sèks · Mizajou Aug 28, 2026 · NCT06423430

NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

Ap rekriteFaz 3
  • Neurocrine Clinical Site, Tampa
Laj 18 ak plis · Tout sèks · Mizajou Aug 11, 2026 · NCT06911112

A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)

Ap rekriteFaz 3
  • K2 Medical Research (Tampa), Tampa
Laj 18 a 74 · Tout sèks · Mizajou Aug 10, 2026 · NCT07592689

A Study of Brenipatide in Adult Participants With Major Depressive Disorder

Ap rekriteFaz 3
  • K2 Medical Research - Tampa, Tampa
Laj 18 a 75 · Tout sèks · Mizajou Aug 6, 2026 · NCT07412756

A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

Ap rekriteFaz 3
  • Neurocrine Clinical Site, Tampa
Laj 18 ak plis · Tout sèks · Mizajou Jul 24, 2026 · NCT07196501

Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

Ap rekriteFaz 3
  • Neurocrine Clinical Site, Tampa
  • Neurocrine Clinical Site, Tampa
Laj 18 ak plis · Tout sèks · Mizajou Jul 24, 2026 · NCT06966401

A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)

Ap rekriteFaz 2
  • University of South Florida, Psychiatry and Behavioral Neurosciences, Tampa
Laj 18 a 65 · Tout sèks · Mizajou May 11, 2026 · NCT06524830

Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)

Ap rekriteFaz 2
  • Autobahn Site #148, Tampa
Laj 18 a 65 · Tout sèks · Mizajou Jan 20, 2026 · NCT06633016

Study of ALTO-300 in MDD

Ap rekriteFaz 2
  • Site 221, Tampa
Laj 18 a 70 · Tout sèks · Mizajou Jul 24, 2025 · NCT05922878

Etid Twoub depresif majè nan lòt vil

Lòt etid nan Tampa

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.